Editorial
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 7, 2006; 12(45): 7233-7238
Published online Dec 7, 2006. doi: 10.3748/wjg.v12.i45.7233
Figure 2
Figure 2 The role of different T cell subsets in colorectal cancer. Activated CD4+ T cells can release growth factors and thereby lead to tumor progression or activate tumor specific CD8+ T cells. Secretion of TGFβ can induce adaptive Tregs, which may suppress the anti-tumor immune response. Once activated, Tregs can be suppressed by IL-6 derived from CD4+ T cells.